WHITEHAWK THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Operating Lease Right-of-Use Assets of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-12
- 2025-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2025-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2025-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2025-03-31: Operating Lease, Right-of-Use Asset $0.00.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $787.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $886.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $982.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.08M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.17M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.26M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.35M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.44M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.52M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $1.57M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.65M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $518.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $557.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $597.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $9.45K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $37.16K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $119.00K 10-K · filed 2022-03-17 | $63.92K 10-K · filed 2021-03-11 |
| 2020-09-30 | $89.76K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $114.71K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $138.82K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $162.12K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $424.75K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $472.13K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $517.98K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |